| Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum SL Wang, L Ohrmund, S Hauenstein, J Salbato, R Reddy, P Monk, ... Journal of immunological methods 382 (1-2), 177-188, 2012 | 262 | 2012 |
| microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism S Hajarnis, R Lakhia, M Yheskel, D Williams, M Sorourian, X Liu, ... Nature communications 8 (1), 1-15, 2017 | 184 | 2017 |
| Concentrations of 6-thioguanine nucleotide correlate with trough levels of infliximab in patients with inflammatory bowel disease on combination therapy AJ Yarur, MJ Kubiliun, F Czul, DA Sussman, MA Quintero, A Jain, ... Clinical Gastroenterology and Hepatology 13 (6), 1118-1124. e3, 2015 | 183 | 2015 |
| Plant conserved non-coding sequences and paralogue evolution S Lockton, BS Gaut TRENDS in Genetics 21 (1), 60-65, 2005 | 180 | 2005 |
| Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease EC Lee, T Valencia, C Allerson, A Schairer, A Flaten, M Yheskel, ... Nature communications 10 (1), 4148, 2019 | 125 | 2019 |
| Antibodies to adalimumab are associated with future inflammation in Crohn's patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial F Baert, V Kondragunta, S Lockton, NV Casteele, S Hauenstein, S Singh, ... Gut 65 (7), 1126-1131, 2016 | 111 | 2016 |
| Demography and weak selection drive patterns of transposable element diversity in natural populations of Arabidopsis lyrata S Lockton, J Ross-Ibarra, BS Gaut Proceedings of the National Academy of Sciences 105 (37), 13965-13970, 2008 | 104 | 2008 |
| Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay SL Wang, S Hauenstein, L Ohrmund, R Shringarpure, J Salbato, R Reddy, ... Journal of pharmaceutical and biomedical analysis 78, 39-44, 2013 | 102 | 2013 |
| The evolution of transposable elements in natural populations of self-fertilizing Arabidopsis thaliana and its outcrossing relative Arabidopsis lyrata S Lockton, BS Gaut BMC Evolutionary Biology 10, 1-11, 2010 | 95 | 2010 |
| Dosage compensation and demasculinization of X chromosomes in Drosophila D Bachtrog, NRT Toda, S Lockton Current biology 20 (16), 1476-1481, 2010 | 83 | 2010 |
| The Contribution of Transposable Elements to Expressed Coding Sequence in Arabidopsis thaliana S Lockton, BS Gaut Journal of molecular evolution 68, 80-89, 2009 | 82 | 2009 |
| 565 novel infliximab (IFX) and antibody-to-infliximab (ATI) assays are predictive of disease activity in patients with Crohn's disease (CD) BG Feagan, S Singh, S Lockton, S Hauenstein, L Ohrmund, LJ Croner, ... Gastroenterology 5 (142), S-114, 2012 | 59 | 2012 |
| Serum adalimumab levels and antibodies correlate with endoscopic intestinal inflammation and inflammatory markers in patients with inflammatory bowel disease AJ Yarur, AR Deshpande, DA Sussman, S Hauenstein, S Lockton, ... Clin Res Highlights IBD Diagn Anti-Tumor Necrosis Factor Monit 9 (8 …, 2013 | 40 | 2013 |
| 490 Prevalence of antibodies to adalimumab (ATA) and correlation between ATA and low serum drug concentration on CRP and clinical symptoms in a prospective sample of IBD patients FS Velayos, S Sheibani, S Lockton, S Hauenstein, S Singh, JP Terdiman, ... Gastroenterology 5 (144), S-91, 2013 | 39 | 2013 |
| Methods for improving inflammatory bowel disease diagnosis F Princen, S Lockton, LJ Croner, FA Fletcher, T Stockfisch, S Singh US Patent 8,715,943, 2014 | 23 | 2014 |
| Adaptive Evolution of Genes Duplicated from the Drosophila pseudoobscura neo-X Chromosome RP Meisel, BB Hilldorfer, JL Koch, S Lockton, SW Schaeffer Molecular biology and evolution 27 (8), 1963-1978, 2010 | 16 | 2010 |
| Methods for improving inflammatory bowel disease diagnosis F Princen, S Lockton, LJ Croner, FA Fletcher, T Stockfisch, S Singh US Patent App. 14/229,715, 2015 | 11 | 2015 |
| Antibodies to adalimumab predict inflammation in Crohn’s patients on maintenance adalimumab therapy FJ Baert, S Lockton, S Hauenstein, S Singh, A Gils, S Vermeire Gastroenterology 146, S242, 2014 | 9 | 2014 |
| 492 Trough levels and antidrug antibodies predict safety and success of restarting Infliximab after a long drug holiday FJ Baert, D Drobne, V Ballet, A Gils, NV Casteele, S Hauenstein, S Singh, ... Gastroenterology 144 (5), S-91-S-92, 2013 | 9 | 2013 |
| 166 Combined Serologic, Genetic, and Inflammatory Markers Can Accurately Differentiate Non-IBD, Crohn's Disease, and Ulcerative Colitis Patients SE Plevy, TP Stockfisch, S Lockton, LJ Croner, S Singh, F Princen Gastroenterology 5 (142), S-41, 2012 | 9 | 2012 |
